Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

INTRODUCTION: Boceprevir was not previously studied with peginterferon alfa-2a/ribavirin in phase III trials in treatment-naïve chronic hepatitis C patients. The international phase IIIb/IV TriCo study was, therefore, designed to evaluate boceprevir in combination with peginterferon alfa-2a/ribaviri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferenci, Peter, Caruntu, Florin A., Lengyel, Gabriella, Messinger, Diethelm, Bakalos, Georgios, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929089/
https://www.ncbi.nlm.nih.gov/pubmed/27228998
http://dx.doi.org/10.1007/s40121-016-0110-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929089/
https://www.ncbi.nlm.nih.gov/pubmed/27228998
http://dx.doi.org/10.1007/s40121-016-0110-5

Ejemplares similares